• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病研究中的动物模型——历史、现状与未来展望

Animal Models in Diabetic Research-History, Presence, and Future Perspectives.

作者信息

Pandey Shashank, Chmelir Tomas, Chottova Dvorakova Magdalena

机构信息

Biomedical Center, Faculty of Medicine in Pilsen, Charles University, 323 00 Pilsen, Czech Republic.

Department of Pharmacology and Toxicology, Faculty of Medicine in Pilsen, Charles University, 323 00 Pilsen, Czech Republic.

出版信息

Biomedicines. 2023 Oct 20;11(10):2852. doi: 10.3390/biomedicines11102852.

DOI:10.3390/biomedicines11102852
PMID:37893225
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10603837/
Abstract

Diabetes mellitus (DM) is a very serious disease, the incidence of which has been increasing worldwide. The beginning of diabetic research can be traced back to the 17th century. Since then, animals have been experimented on for diabetic research. However, the greatest development of diabetes research occurred in the second half of the last century, along with the development of laboratory techniques. Information obtained by monitoring patients and animal models led to the finding that there are several types of DM that differ significantly from each other in the causes of the onset and course of the disease. Through different types of animal models, researchers have studied the pathophysiology of all types of diabetic conditions and discovered suitable methods for therapy. Interestingly, despite the unquestionable success in understanding DM through animal models, we did not fully succeed in transferring the data obtained from animal models to human clinical research. On the contrary, we have observed that the chances of drug failure in human clinical trials are very high. In this review, we will summarize the history and presence of animal models in the research of DM over the last hundred years. Furthermore, we have summarized the new methodological approaches, such as "organ-on-chip," that have the potential to screen the newly discovered drugs for human clinical trials and advance the level of knowledge about diabetes, as well as its therapy, towards a personalized approach.

摘要

糖尿病(DM)是一种非常严重的疾病,其发病率在全球范围内一直在上升。糖尿病研究的开端可以追溯到17世纪。从那时起,动物就被用于糖尿病研究实验。然而,糖尿病研究的最大发展发生在上个世纪下半叶,伴随着实验室技术的发展。通过对患者和动物模型的监测所获得的信息导致发现,有几种类型的糖尿病在发病原因和病程上彼此有显著差异。通过不同类型的动物模型,研究人员研究了所有类型糖尿病病症的病理生理学,并发现了合适的治疗方法。有趣的是,尽管通过动物模型在理解糖尿病方面取得了毋庸置疑的成功,但我们并没有完全成功地将从动物模型获得的数据转化为人类临床研究。相反,我们观察到在人类临床试验中药物失败的几率非常高。在这篇综述中,我们将总结过去一百年来动物模型在糖尿病研究中的历史和现状。此外,我们还总结了新的方法学方法,如“芯片器官”,这些方法有可能筛选新发现的药物用于人类临床试验,并将糖尿病及其治疗的知识水平推进到个性化方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45ae/10603837/6eae5cd0b929/biomedicines-11-02852-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45ae/10603837/69e08e3fb872/biomedicines-11-02852-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45ae/10603837/9678f1328968/biomedicines-11-02852-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45ae/10603837/45d8ebc25ebd/biomedicines-11-02852-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45ae/10603837/6eae5cd0b929/biomedicines-11-02852-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45ae/10603837/69e08e3fb872/biomedicines-11-02852-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45ae/10603837/9678f1328968/biomedicines-11-02852-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45ae/10603837/45d8ebc25ebd/biomedicines-11-02852-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45ae/10603837/6eae5cd0b929/biomedicines-11-02852-g004.jpg

相似文献

1
Animal Models in Diabetic Research-History, Presence, and Future Perspectives.糖尿病研究中的动物模型——历史、现状与未来展望
Biomedicines. 2023 Oct 20;11(10):2852. doi: 10.3390/biomedicines11102852.
2
[A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].[日本新药50年历史——抗糖尿病药物的研发进展与糖尿病的流行病学情况]
Yakushigaku Zasshi. 2003;38(1):11-27.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
5
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
6
Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer.纳武利尤单抗致免疫相关性糖尿病酮症酸中毒 1 例并文献复习 **提示**:这是对原文的直译,并未进行润色,可能存在不通顺的地方。
J Immunother Cancer. 2017 May 16;5:40. doi: 10.1186/s40425-017-0245-2. eCollection 2017.
7
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
8
A new concept: the use of vanadium complexes in the treatment of diabetes mellitus.一个新概念:钒配合物在糖尿病治疗中的应用。
Chem Rec. 2002;2(4):237-48. doi: 10.1002/tcr.10029.
9
Familial clustering of type II diabetes mellitus (DM) diagnosed under the age of 40 years in Yemen: Is it early-onset type II DM or maturity-onset diabetes of the young?也门40岁以下诊断出的2型糖尿病(DM)的家族聚集性:是早发型2型糖尿病还是青年发病的成年型糖尿病?
Ann Saudi Med. 1999 Jul-Aug;19(4):308-16. doi: 10.5144/0256-4947.1999.308.
10
Anticancer Drug Development: The Way Forward.抗癌药物研发:前进之路
Oncologist. 1996;1(3):180-181.

引用本文的文献

1
Role of High-Fat Diet Alone on Lipids, Arterial Wall and Hippocampal Neural Cell Alterations in Animal Models and Their Implications for Humans.高脂饮食单独对动物模型中脂质、动脉壁和海马神经细胞改变的作用及其对人类的影响。
Biology (Basel). 2025 Aug 1;14(8):971. doi: 10.3390/biology14080971.
2
Exo-hydrogel therapy: a revolutionary approach to managing diabetic complications.外泌体水凝胶疗法:一种治疗糖尿病并发症的革命性方法。
J Nanobiotechnology. 2025 Aug 11;23(1):558. doi: 10.1186/s12951-025-03621-6.
3
Type 2 diabetes abates retrograde collateral flow and promotes leukocyte adhesion following ischemic stroke.

本文引用的文献

1
Rodent models for diabetes.糖尿病的啮齿动物模型。
3 Biotech. 2023 Mar;13(3):80. doi: 10.1007/s13205-023-03488-0. Epub 2023 Feb 9.
2
2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023.2. 糖尿病的分类和诊断:2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S19-S40. doi: 10.2337/dc23-S002.
3
Insulin-producing cell clusters derived from human gingival mesenchymal stem cells as a model for diabetes research.源自人牙龈间充质干细胞的胰岛素生成细胞簇作为糖尿病研究模型
2型糖尿病会减弱缺血性中风后的逆行侧支血流,并促进白细胞黏附。
J Cereb Blood Flow Metab. 2025 May 29:271678X251338203. doi: 10.1177/0271678X251338203.
4
Type 2 diabetes remodels collateral circulation and promotes leukocyte adhesion following ischemic stroke.2型糖尿病会重塑缺血性中风后的侧支循环并促进白细胞黏附。
bioRxiv. 2024 Oct 23:2024.10.23.619748. doi: 10.1101/2024.10.23.619748.
5
Effects of Some Olive Fruits-Derived Products on Oxidative Stress and Cardiovascular Biomarkers on Experimental Diabetes Mellitus.某些橄榄果实衍生产品对实验性糖尿病氧化应激和心血管生物标志物的影响
Antioxidants (Basel). 2024 Sep 18;13(9):1127. doi: 10.3390/antiox13091127.
6
Methylglyoxal and Advanced Glycation End Products (AGEs): Targets for the Prevention and Treatment of Diabetes-Associated Bladder Dysfunction?甲基乙二醛与晚期糖基化终末产物(AGEs):预防和治疗糖尿病相关膀胱功能障碍的靶点?
Biomedicines. 2024 Apr 23;12(5):939. doi: 10.3390/biomedicines12050939.
7
Animal Models for Understanding the Mechanisms of Beta Cell Death during Type 2 Diabetes Pathogenesis.用于理解2型糖尿病发病机制中β细胞死亡机制的动物模型
Biomedicines. 2024 Feb 20;12(3):473. doi: 10.3390/biomedicines12030473.
Mol Biol Rep. 2022 Dec;49(12):11973-11982. doi: 10.1007/s11033-022-08008-6. Epub 2022 Oct 21.
4
Phytochemical Analysis and hypoglycemic potential of Filago hurdwarica (Wall. ex DC.) Wagenitz in alloxan induced diabetic mice.印度车前草(Wall. ex DC.) Wagenitz 的植物化学分析及其对四氧嘧啶诱导糖尿病小鼠的降血糖潜力。
Braz J Biol. 2022 Oct 10;84:e261518. doi: 10.1590/1519-6984.261518. eCollection 2022.
5
iPSCs in Neurodegenerative Disorders: A Unique Platform for Clinical Research and Personalized Medicine.诱导多能干细胞在神经退行性疾病中的应用:临床研究和个性化医疗的独特平台。
J Pers Med. 2022 Sep 10;12(9):1485. doi: 10.3390/jpm12091485.
6
Repeated Low-Dose Streptozotocin and Alloxan Induced Long-Term and Stable Type 1 Diabetes Model in Beagle Dogs.重复小剂量链脲佐菌素和阿霉素诱导比格犬长期稳定的 1 型糖尿病模型。
Biomed Res Int. 2022 Aug 8;2022:5422287. doi: 10.1155/2022/5422287. eCollection 2022.
7
A novel model mouse for type 2 diabetes mellitus with early onset and persistent hyperglycemia.一种具有早发和持续高血糖的 2 型糖尿病新型模型鼠。
Exp Anim. 2022 Nov 10;71(4):510-518. doi: 10.1538/expanim.22-0061. Epub 2022 Jul 28.
8
From "organs on a chip" to "patient on a chip".从“芯片上的器官”到“芯片上的患者”
Innovation (Camb). 2022 Jul 6;3(5):100282. doi: 10.1016/j.xinn.2022.100282. eCollection 2022 Sep 13.
9
Zebrafish: A Model to Study and Understand the Diabetic Nephropathy and Other Microvascular Complications of Type 2 Diabetes Mellitus.斑马鱼:一种用于研究和理解2型糖尿病的糖尿病肾病及其他微血管并发症的模型。
Vet Sci. 2022 Jun 22;9(7):312. doi: 10.3390/vetsci9070312.
10
Induced pluripotent stem cell-based organ-on-a-chip as personalized drug screening tools: A focus on neurodegenerative disorders.基于诱导多能干细胞的芯片器官作为个性化药物筛选工具:聚焦神经退行性疾病
J Tissue Eng. 2022 May 9;13:20417314221095339. doi: 10.1177/20417314221095339. eCollection 2022 Jan-Dec.